Phase I study of belantamab mafodotin in combination with standard of care in transplant-ineligible newly DREAMM-9 interim Meeting Abstract
| Authors: | Usmani, S. Z.; Mielnik, M.; Garg, M.; Sandhu, I.; Abdallah, A. O.; Koh, Y.; Oriol, A.; Quach, H.; Weisel, K. C.; Alonso, A. A.; Ocio, E. M.; Janowski, W.; Min, C. K.; Ramasamy, K.; Sánchez, R. G.; RodrÃguez-Otero, P.; Msc, C. B.; Egger, J. L.; Kaisermann, M. C.; Hus, M. |
| Abstract Title: | Phase I study of belantamab mafodotin in combination with standard of care in transplant-ineligible newly DREAMM-9 interim |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 497 |
| End Page: | 499 |
| Language: | English |
| ACCESSION: | WOS:001415654100047 |
| DOI: | 10.1182/blood-2024-198669 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
